US PRECISION Implementation Study
Condition: Asthma
MeSH terms: Asthma
Study type: Interventional

Summary: 
      The primary objective of this community program intervention study is to assess the process
      and potential benefits of integrating the AIRQ™, Asthma Checklist, and educational resources
      (PRECISION program) into clinical practice using either in-person or telehealth visits.

      The secondary objectives are to assess asthma patients' clinic visit experiences when the
      AIRQ™, the Asthma Checklist, and educational resources (PRECISION program) are utilized as
      part of a telehealth or in-person visit with their HCP, and to explore change in AIRQ™ scores
      from the initial visit to follow-up visit(s) (when available).
    

Detailed description: 
      This community program intervention study will examine the process of integrating the AIRQ™,
      Asthma Checklist, and educational resources (PRECISION program) into clinical practice using
      either in-person or telehealth visits. Providers use of patients' responses to the AIRQ™,
      Asthma Checklist, and educational resources to guide treatment and asthma work-up and
      management also will be examined. The study duration is 12-months, with study enrollment
      lasting nine (9) months for each site (implementation stage), and an additional three (3)
      months of follow-up to assess the sustainability of using the PRECISION program in clinical
      practice (sustainability stage). The nine-month implementation stage will allow for the
      recruitment of approximately 50 patients at each site (maximum of 75 patients at each site)
      for an initial study visit, plus the potential for follow-up visit(s). The three-month
      sustainability stage will allow for sites to continue to implement the PRECISION program in
      their clinical practice and for sites to describe any continued benefits of using the
      PRECISION program at their site.

      Approximately fifteen (15) to twenty (20) clinical sites will be recruited to participate in
      this study, categorized into the following four practice clusters: (1) primary care site
      (e.g., private practice, FQHC; (2) specialty care site (pulmonary, asthma/immunology); and
      (3) novel sites (e.g., pharmacy, nurse practitioners, nurse educators, prescribers and
      Non-prescribers, telehealth component of Allergy and Asthma Network. While all sites will be
      able to conduct both in-person and telehealth visits, sites will aim to conduct a minimum of
      approximately 25% of their initial patient visit using a telehealth platform. Both platforms
      (in-person and telehealth) can be used for the follow-up visit(s) for all practice types.
    

Intervention name(s): AIRQ; Asthma Checklist; PRECISION Program (Educational Resources)
Intervention type(s): Behavioral; Behavioral; Behavioral
Intervention description(s): A validated tool designed to identify patients who may be at risk for adverse outcomes from uncontrolled asthma.; A validated, 3-page tool, based on GINA and NAEPP guidelines to assist providers with recognition, evaluation, and optimization of all patients with asthma. In this study, healthcare providers will be required to complete the assess component (page 1) of the Asthma Checklist .; Educational resources accessible to all providers in the study. There are provider-facing and patient-facing educational materials that can be accessed during the patient visit or as resources for before/after visits. Resources can be downloaded and sent to patients per the discretion of providers.
Intervention model: Single Group Assignment
Masking: None (Open Label)
Primary purpose: Health Services Research